Beck Bode LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,510	Closed	-$1.24M	–	155
2023 Q1	$1.24M	Sell	1,510 -201	-12%	-$152K	0.3%	82
2022 Q4	$1.23M	Buy	1,711 +1,280	+297%	+$944K	0.28%	81
2022 Q3	$297K	Buy	431 +4	+0.9%	+$2.52K	0.06%	150
2022 Q2	$252K	Sell	427 -27	-6%	-$17.6K	0.05%	161
2022 Q1	$317K	Buy	+454	New	+$287K	0.07%	119
2021 Q4	–	Sell	-12,681	Closed	-$7.67M	–	100
2021 Q3	$7.67M	Sell	12,681 -191	-1%	-$119K	2.14%	22
2021 Q2	$7.19M	Buy	12,872 +50	+0.4%	+$25.3K	1.98%	23
2021 Q1	$6.07M	Buy	+12,822	New	+$6.24M	1.87%	24
2020 Q4	–	Sell	-37	Closed	-$21K	–	217
2020 Q3	$21K	Buy	+37	New	+$22.4K	0.01%	166
2020 Q2	–	Sell	-6,132	Closed	-$3.23M	–	54
2020 Q1	$3.23M	Buy	+6,132	New	+$2.53M	1.48%	28